tiprankstipranks
Trending News
More News >
CanSino Biologics, Inc. Class H (HK:6185)
:6185

CanSino Biologics, Inc. Class H (6185) Similar Stocks

Compare
2 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
CanSino Biologics, Inc. Class H
HK$35.20
HK$10.53B
79.77%
Guangzhou Baiyunshan Pharmaceutical Holdings Company
$2.23
$5.69B
9.75
-10.08%
0 Buy
0 Hold
0 Sell
Moderate Sell
Livzon Pharmaceutical Group
$3.82
$4.21B
12.02
28.14%
0 Buy
1 Hold
0 Sell
Hold
Shanghai Fosun Pharmaceutical (Group) Co
$1.96
$8.72B
12.84
20.68%
0 Buy
1 Hold
0 Sell
Hold
China Resources Pharmaceutical Group Ltd.
€0.55
€3.55B
8.03
-12.70%
0 Buy
0 Hold
0 Sell
Moderate Buy
Hansoh Pharmaceutical Group Company Limited
HK$31.15
HK$185.25B
38.97
98.85%
3 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:6185
CanSino Biologics, Inc. Class H
34.30
15.22
79.77%
GZPHF
Guangzhou Baiyunshan Pharmaceutical Holdings Company
2.23
-0.25
-10.08%
LVZPF
Livzon Pharmaceutical Group
3.78
0.83
28.14%
SFOSF
Shanghai Fosun Pharmaceutical (Group) Co
1.96
0.34
20.99%
DE:640
China Resources Pharmaceutical Group Ltd.
0.55
-0.08
-12.70%
HK:3692
Hansoh Pharmaceutical Group Company Limited
31.00
15.41
98.85%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis